Status:
UNKNOWN
The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children
Lead Sponsor:
Assiut University
Conditions:
Esophageal Stricture
Eligibility:
All Genders
6-18 years
Phase:
PHASE4
Brief Summary
To evaluate the efficacy of Intra-lesional triamcinolone injection in the management of refractory benign esophageal Stricture in children.
Detailed Description
Oesophageal stricture is a commonly encountered clinical problem, especially in gastroenterology. It occurs due to narrowing of oesophagus, which results in swallowing difficulty. Oesophageal strictur...
Eligibility Criteria
Inclusion
- All patients admitted to Assiut University Children Hospital with:
- refractory benign esophageal stricture(inability to successfully remediate the anatomic problem to a diameter of at least 14 mm over five sessions at two-week interval)
- inability to maintain a satisfactory luminal diameter for four weeks once the target diameter of 14 mm has been achieved
Exclusion
- Pharyngeal stenosis precluding endoscopic examination and dilatation
- tracheo-esophageal fistula,
- gastric cicatrization that precluded safe placement of aguidewire
- any patient who was unfit for general anesthesia.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04524897
Start Date
December 1 2020
End Date
March 1 2022
Last Update
October 27 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.